A new study reveals that junk food and drug use are hindering life expectancy gains in the U.S., despite technological ...
Months after posting weight loss of 7.5% at 36 days for patients taking MET-097i, Metsera releases mid-stage results of just ...
China is adapting its Life Sciences policy to bolster innovation and data transparency. Big Pharma is taking note.
What does the latest science say about the use of GLP-1 meds to treat obesity in people without diabetes?A review of 26 ...
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.
How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...
Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.
For about 25 million Americans who suffer from obstructive sleep apnea, there are various effective treatments such as CPAP breathing machines, surgery, a dental mouthpiece and even an implantable pac ...
11hon MSN
It's no secret that Ozempic isn't going anywhere, but the weight loss drug category does seem to be rapidly evolving.
With 13 states offering coverage, it’s already a $3.9 billion cost. Some state officials say reducing obesity will save programs money in the long run.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback